KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) FCF Margin (2016 - 2026)

Quest Diagnostics' FCF Margin history spans 18 years, with the latest figure at 5.66% for Q1 2026.

  • On a quarterly basis, FCF Margin fell 176.0% to 5.66% in Q1 2026 year-over-year; TTM through Mar 2026 was 11.76%, a 136.0% increase, with the full-year FY2025 number at 12.32%, up 311.0% from a year prior.
  • FCF Margin hit 5.66% in Q1 2026 for Quest Diagnostics, down from 10.94% in the prior quarter.
  • Over the last five years, FCF Margin for DGX hit a ceiling of 19.89% in Q4 2023 and a floor of 1.42% in Q1 2023.
  • Historically, FCF Margin has averaged 10.66% across 5 years, with a median of 11.18% in 2024.
  • The widest YoY moves for FCF Margin: up 1187bps in 2023, down -1739bps in 2023.
  • Tracing DGX's FCF Margin over 5 years: stood at 8.02% in 2022, then soared by 148bps to 19.89% in 2023, then crashed by -35bps to 13.01% in 2024, then dropped by -16bps to 10.94% in 2025, then crashed by -48bps to 5.66% in 2026.
  • Business Quant data shows FCF Margin for DGX at 5.66% in Q1 2026, 10.94% in Q4 2025, and 14.88% in Q3 2025.